EBV-001

N/A

Report date: 2025/01/26 16:33:51

Base Information

Drug NameEBV-001
Drug Alias NameEBV-VLP vaccine (Helmholtz Zentrum Munchen)EBV-001
ClassificationVaccines > Application > Prophylactic vaccineBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsLymphoproliferative DisordersMultiple SclerosisNeoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHelmholtz Zentrum Muenchen
China Registration ClassN/A

Develop Information

Active CompaniesEBViously Gmbh
Inactive CompaniesHelmholtz Zentrum MuenchenAscenion
Active IndicationsLymphoproliferative DisordersMultiple SclerosisNeoplasms +[5] 
Inactive IndicationsEpstein-Barr Virus Infections

Other Information

ATC CodeN/A
Related LinksN/A